N. prodotti: 0
Totale ordine: € 0,00
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index
Online ISSN 1827-1650
Laura MELADO VIDALES 1, Alonso FERNANDEZ NISTAL 2, Vicente MARTINEZ FERNANDEZ 3, Victoria VERDU MERINO 4, Isidoro BRUNA CATALAN 5, Jose M. BAJO ARENAS 6
1 Gyn/Ob and IVF Specialist in Al Ain Fertility Centre, Al Ain, Abu Dhabi, UAE; 2 Pharmacology Department, Complutense University, Madrid, Spain; 3 Pharmacology Department, Navarra University, Navarra, Spain; 4 Medical department, Ginefiv Clinic, Madrid, Spain; 5 HM Fertility Centers, Madrid, Spain; 6 Ginefiv Clinic, Madrid, Spain
BACKGROUND: To assess correlation between controlled ovarian hyperstimulation (COH) outcome parameters and anti-Müllerian hormone (AMH) serum levels during in vitro fertilization (IVF) treatment in women with varying ovarian reserve levels.
METHODS: Prospective study of 46 women undergoing GnRH-antagonist short protocol for IVF. Participants included women with low ovarian reserve (n=11), normoreserve (n=16), and polycystic ovarian syndrome (PCOS; n=19). AMH was measured on menstrual cycle day 1-3 (basal AMH), on the day of GnRH-antagonist administration (AMH-GnRH), on the day of hCG administration (AMH-hCG), and in follicular fluid on the day of oocyte retrieval (AMH-FF).
RESULTS: Basal AMH was significantly correlated (p<0.001) with antral follicle count and number of follicles >11mm on hCG day (p<0.05). Both basal AMH and AMH-GnRH were significantly correlated (p<0.05) with the number of oocytes retrieved and metaphase II. AMH-hCG was correlated with top quality embryos (p=0.04). No correlations were found between COH outcome parameters and AMH-FF.
CONCLUSIONS: Basal AMH serum concentration was the strongest predictor of oocyte yield. AMH concentration at the mid-follicular phase was also a good predictor of oocyte yield and this marker was the only useful ovarian reserve indicator during the follicle growth process to predict IVF outcomes. AMH-hCG levels appear to predict embryo quality. AMH levels during the COH can provide valuable data to help individualize treatment and predict COH results.